-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23

Benzinga·04/28/2026 15:26:23
Listen to the news
Guggenheim analyst Debjit Chattopadhyay initiates coverage on Satellos Bioscience (NASDAQ:MSLE) with a Buy rating and announces Price Target of $23.